Skip to main content
SpringerLink
Log in

Deauville score evaluation of interim PET/CT in primary mediastinal large B-cell lymphoma

  • Letter to the Editor
  • Published:
European Journal of Nuclear Medicine and Molecular Imaging Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

References

  1. Lazarovici J, Terroir M, Arfi-Rouche J, Michot JM, Mussot S, Florea V, et al. Poor predictive value of positive interim FDG-PET/CT in primary mediastinal large B-cell lymphoma. Eur J Nucl Med Mol Imaging. 2017;44:2018–24.

    Article  Google Scholar 

  2. Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127:2375–90.

    Article  CAS  Google Scholar 

  3. Barrington SF, Mikhaeel NG, Kostakoglu L, Meignan M, Hutchings M, Müeller SP, et al. Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group. J Clin Oncol. 2014;32:3048–58.

    Article  Google Scholar 

  4. Meignan M, Gallamini A, Meignan M, Gallamini A, Haioun C. Report on the first international workshop on interim-PET-scan in lymphoma. Leuk Lymphoma. 2009;50:1257–60.

    Article  Google Scholar 

  5. Zinzani PL, Ribrag V, Moskowitz CH, Michot JM, Kuruvilla J, Balakumaran A, et al. Safety and tolerability of pembrolizumab in patients with relapsed/refractory primary mediastinal large B-cell lymphoma. Blood. 2017;130:267–70.

    Article  CAS  Google Scholar 

  6. Armand P, Rodig S, Melnichenko V, Thieblemont C, Bouabdallah K, Tumyan G, et al. Pembrolizumab in relapsed or refractory primary mediastinal large B-cell lymphoma. J Clin Oncol. 2019;37:3291–9.

    Article  CAS  Google Scholar 

  7. Neelapu SS, Locke FL, Bartlett NL, Lekakis LJ, Miklos DB, Jacobson CA, et al. Axicabtagene ciloleucel CAR T-cell therapy in refractory large B-cell lymphoma. N Engl J Med. 2017;377:2531–44.

    Article  CAS  Google Scholar 

  8. Kochenderfer JN, Dudley ME, Kassim SH, Somerville RP, Carpenter RO, Stetler-Stevenson M, et al. Chemotherapy-refractory diffuse large B-cell lymphoma and indolent B-cell malignancies can be effectively treated with autologous T cells expressing an anti-CD19 chimeric antigen receptor. J Clin Oncol. 2015;33:540–9.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank Dr. Peter Liao for the English editing.

Funding

This study was supported by the National Natural Science Foundation of China (81830007, 82070204, and 81670176), Shanghai Municipal Education Commission Gaofeng Clinical Medicine (20152206 and 20152208), Multicenter Clinical Research Project by Shanghai Jiao Tong University School of Medicine (DLY201601), Clinical Research Plan of Shanghai Hospital Development Center (SHDC2020CR1032B), Chang Jiang Scholars Program, and Samuel Waxman Cancer Research Foundation.

Author information

Author notes

  1. Wei Qin, Xufeng Jiang and Jianhua You contributed equally to this work.

Authors and Affiliations

  1. Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, 197 Rui Jin Er Road, Shanghai, 200025, China

    Wei Qin, Jianhua You, Qing Shi, Rong Shen, Shu Cheng, Pengpeng Xu, Ying Qian, Li Wang & Weili Zhao

  2. Department of Nuclear Medicine, Shanghai Rui Jin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

    Xufeng Jiang, Rui Guo & Biao Li

  3. Department of Pathology, Shanghai Rui Jin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

    Lei Dong

  4. Laboratory of Molecular Pathology, Pôle de Recherches Sino-Français en Science du Vivant et Génomique, Shanghai, China

    Li Wang & Weili Zhao

Authors
  1. Wei Qin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Xufeng Jiang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jianhua You
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Rui Guo
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Qing Shi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Lei Dong
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Rong Shen
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Shu Cheng
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Pengpeng Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Ying Qian
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Biao Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Li Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Weili Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

W.Q. and L.W. analyzed the data and wrote the manuscript. X.J. and R.G. reviewed the PET/CT scans. J.Y., S.C., P.X., Y.Q., and B.L. recruited patients and gathered detailed clinical information. W.Q., Q.S., and R.S. collected the data. L.D. reviewed the histological diagnoses. W.Z. conceived the study, directed and supervised research, and wrote the manuscript.

Corresponding authors

Correspondence to Li Wang or Weili Zhao.

Ethics declarations

Ethics approval

The study was approved by the Shanghai Ruijin Hospital Review Board with written informed consent obtained in accordance with the Declaration of Helsinki.

Consent to participate

Written informed consent was obtained from the included patients for participation in this study.

Consent for publication

The authors affirm that the human research participants provided informed consent for the publication of the studied data.

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Hematology.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Qin, W., Jiang, X., You, J. et al. Deauville score evaluation of interim PET/CT in primary mediastinal large B-cell lymphoma. Eur J Nucl Med Mol Imaging 48, 3347–3350 (2021). https://doi.org/10.1007/s00259-021-05310-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00259-021-05310-6

Search

Navigation